Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-044963
Filing Date
2013-09-19
Accepted
2013-09-19 19:44:02
Documents
2
Period of Report
2013-09-19

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c598537_3x1.html 3  
1 MAIN DOCUMENT DESCRIPTION c598537_3x1.xml 3 3592
2 POWER OF ATTORNEY c598537_24x1.htm EX-24 5276
  Complete submission text file 0001209191-13-044963.txt   10555
Mailing Address 325 VASSAR STREET CAMBRIDGE MA 02139
Business Address 325 VASSAR STREET CAMBRIDGE MA 02139 6174913400
BIND Therapeutics, Inc (Issuer) CIK: 0001385228 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10A 60-LETIYA OKTYABRYA PROSPECT MOSCOW 1Z 117036
Business Address 10A 60-LETIYA OKTYABRYA PROSPECT MOSCOW 1Z 117036 495-988-5388
RUSNANO (Reporting) CIK: 0001548606 (see all company filings)

State of Incorp.: 1Z
Type: 3 | Act: 34 | File No.: 001-36072 | Film No.: 131106509